We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Rising Arrhythmia Incidence Driving Electrophysiology Devices Market

By HospiMedica International staff writers
Posted on 18 Oct 2011
The increasing incidence of arrhythmias, the adoption of remote navigation technologies, and the approval of new products for the treatment of atrial fibrillation (AF) are some of the factors that are expected to drive the growth of the global electrophysiology devices market. More...
These are the latest findings of GlobalData (Princeton, NJ, USA), a leading business information company.

Existing catheter-based approaches for AF are time consuming, complicated, and ineffective in around 20% of cases. The increase in demand for ablative therapy with the growing prevalence of AF has fueled the development of safer and more efficient treatment techniques. Over the last decade, newer electrophysiology technologies have entered the market; these emerging techniques strive to reduce procedure times, eliminate radiation exposure, and achieve permanent destruction of the targeted heart tissue without causing damage to the surrounding structures. The prominent technology among them is remote navigation technology, which uses either use robotics or magnetic fields to steer and direct catheters.

Robotic-guided systems have brought about a shift in the catheter ablation treatment of AF; while the procedure is essentially the same as manual catheter ablation, the use of robotics in allows enhanced precision, stability, and the dexterity needed to perform ablative procedures, with reduced procedure time, also reducing the risk of emboli formation that can potentially lead to lung embolism or stroke. The remote operation of the robotic-guided catheter ablation technique also limits physician’s exposure to fluoroscopy or radiation. The use of long introducers during access helps avoid vascular complications, reducing energy (since the robotic systems provide better contact), and monitoring esophageal temperature helps to avoid any damage.

One such technology is the Sensei Robotic Catheter System, a product of Hansen Medical (Mountain View, CA, USA).The Sensei is an electromechanical system that facilitates catheter navigation via two steerable sheathes incorporating an ablation catheter; both outer and inner sheath are manipulated by a pull-wire mechanism in the robotic arm, which obeys the commands of the central workstation placed in the control room. A master console with multiple video monitors and a three dimensional (3D) joystick facilitate a broad range of motion in any direction.

Magnetic navigation systems, on the other hand, are based on an interaction between a magnetic field of a specific direction and magnitude and multiple tiny magnets on the tip and shaft of the interventional catheter. The Niobe Magnetic Navigation System from Stereotaxis (St. Louis, MO, USA) is currently the only catheter navigation system available. The system employs two permanent magnets that are positioned on either side of the patient, generating a magnetic navigation field, which is less than 10% of the strength of the fields generated by typical magnetic resonance imaging (MRI) equipment. The magnetic field generated is sufficient to steer and change the direction of the magnetically tipped catheters.

However, despite various advantages of remote navigation systems, concerns such as higher system cost, cost involved in renovating the room settings to accommodate the equipment, and catheter compatibility has restricted the wider use of robotic-guided systems and magnetic navigation systems. The global electrophysiology devices market was valued at US$1.1 billion in 2010 and is forecast to reach $1.6 billion by 2017, representing a compound annual growth rate (CAGR) of 6%.

Related Links:

GlobalData
Hansen Medical
Stereotaxis




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Cervical Seal
Omni Lok
New
Powered Surgical Stapler
ECHELON 3000 Stapler
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.